跳至主要内容
临床试验/NCT02619773
NCT02619773已完成不适用

The Use of Mupirocin Dressings and Its Effect on Surgical Site Infections in Elective Colorectal Surgery: A Prospective, Randomized Controlled Trial

Gundersen Lutheran Medical Foundation2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2015年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
2
主要终点
Surgical Site Infection

研究概览

简要总结

Infections at the site of surgical incisions (SSIs) are the most common infection among surgical patients. Although all patients undergoing surgical procedures are at risk for developing SSIs, colorectal surgery has had consistently had high rates of SSIs, ranging from 3-45%. These infections can increase the length of hospital stay, and increase the rate of readmissions and costs.

Further research is needed to study the effects of mupirocin in general surgery. A recent study compared colorectal SSI rates between mupirocin and standard gauze surgical dressings. The results of this show that mupirocin has the greatest effect on reducing SSI rate when compared to standard gauze dressings. However, these studies have not been performed in the United States and have only been studied on a very specific patient population.

The purpose of this study is to assess the rate of infections at the surgical incision after colorectal surgery when a mupirocin dressing is placed versus a standard gauze dressing without mupirocin.

详细描述

Surgical site infections (SSIs) are the most common nosocomial infection among surgical patients and are the third most common nosocomial infection among all hospitalized patients.1 Although all patients undergoing surgical procedures are at risk for developing SSIs, colorectal surgery has consistently had high rates of surgical site infections, ranging from 3-45%. Numerous studies have shown the adverse effects of SSIs, including increased length of hospital stay, morbidity, mortality, readmissions and costs. In a recent study analyzing various surgical procedures, including colorectal operations, surgical site infection was found to be the number one cause of unplanned readmission.

Studies have been performed showing that intranasal mupirocin may have a role in reduction of SSI in cardiac and orthopedic surgery. However, there has been minimal investigation on the effects of topical mupirocin in general surgery. A recent study from Spain compared colorectal SSI rates between mupirocin dressings, silver-impregnated dressings, and standard gauze surgical dressings. The results of this show that mupirocin has the greatest effect on reducing SSI rate when compared to standard gauze and silver-impregnated dressings. However, these studies have not been performed in the United States and have only been studied on open, colorectal oncologic surgery.

The aim of this study is to compare mupirocin dressings to standard surgical dressings and their respective SSI rates at a United States community hospital in patients undergoing elective open and minimally invasive colorectal surgery.

A single-center prospective, randomized study will be performed. Patients who will undergo elective colorectal surgery and consent to participate will be randomized (1:1) to one of the following 2 treatment groups:

  1. Island dressings until postoperative day (POD) #2 (which is current practice at Gundersen Health System)
  2. Mupirocin + island dressing until POD#5 Analysis of outcomes will include rate of SSI, and 30-day morbidity and mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Elective Colorectal surgery
  • Open and minimally invasive cases
  • Partial and total Colon resections, Abdominoperineal resection, Low anterior resections, Creation/takedown of colostomy, abdominal procedures for prolapse

排除标准

  • Patients with known allergies to mupirocin
  • Cases in which the skin was intentionally left open at the end of surgery (secondary closure technique)
  • Women who are pregnant or planning to become pregnant

研究组 & 干预措施

Island dressing

No Intervention

Island dressing applied to surgical incision until postoperative day 2. This arm will not undergo any intervention.

Mupirocin dressing

Experimental

Mupirocin + island dressing applied to surgical incision until postoperative day 5.

Intervention: mupirocin ointment applied to extrication incision.

干预措施: mupirocin ointment (Procedure)

结局指标

主要结局

Surgical Site Infection

时间窗: within 30 days postoperative

Surgical site infection defined per ACS NSQIP criteria

次要结局

未报告次要终点

研究者

发起方
Gundersen Lutheran Medical Foundation
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kara Kallies

Academic Researcher

Gundersen Lutheran Medical Foundation

研究点 (2)

Loading locations...

相似试验